Synergetics USA, Inc. (NASDAQ: SURG) announced the signing of a 3 month
extension to March 31, 2009 of the current electrosurgery product
distribution and Malis® trademark licensing agreements with
Codman & Shurtleff, Inc. (“Codman”), an affiliate of Johnson & Johnson,
as ongoing negotiations for longer term agreements between the two
companies ensue.
Under the terms of the extension, Codman will continue to market and
distribute certain bipolar generators and related disposables and
accessories supplied by Synergetics. Additionally, Synergetics and
Codman extended the license agreement providing for the continued
licensing of Synergetics’ Malis® trademark to Codman for use
with certain of its products, including those covered by the
distribution agreement.
About Synergetics USA, Inc.
Synergetics USA, Inc. is a leading medical device company. Through
continuous improvement and development of our people, our mission
is to design, manufacture and market innovative microsurgical
instruments and consumables of the highest quality in order to assist
and enable microsurgeons around the world to provide a better quality of
life for their patients. The Company’s primary focus is on the
microsurgical disciplines of ophthalmology and neurosurgery. Our
distribution channels include a combination of direct and independent
sales organizations and important strategic alliances with market
leaders. The Company’s product lines focus upon precision engineered,
microsurgical, hand-held instruments and the microscopic delivery of
laser energy, ultrasound, electrosurgery, illumination and irrigation,
often delivered in multiple combinations.
Forward-Looking Statements
Some statements in this release may be “forward-looking statements”
for the purposes of the Private Securities Litigation Reform Act of
1995. In some cases forward-looking statements can be identified by
words such as “believe,” “expect,” “anticipate,” “plan,” “potential,”
“continue” or similar expressions. Such forward-looking statements
include risks and uncertainties, and there are important facts that
could cause actual results to differ materially from those expressed or
implied by such forward-looking statements. These facts, risks
and uncertainties are discussed in Synergetics’ Annual Report on Form
10-K for the year ended July 31, 2008, as updated from time to time in
our filings with the Securities and Exchange Commission.
SYNERGETICS USA, INC.
Pamela G. Boone, 636-939-5100
Chief
Financial Officer
http://www.synergeticsusa.com
